Stopping antidepressants for depression in remission
Part of Mental health clinical trials.
This trial compares different ways to safely stop taking an antidepressant when your depression is in remission. It aims to find the best strategy to avoid withdrawal symptoms and keep you well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with depression (a single episode or repeated episodes).
- You are currently taking an antidepressant from a specific list (SSRI, SNRI, TCA, or vortioxetine) for at least 6 months, with a stable dose for the last 2 months.
- Your depression is in remission, meaning you have low scores on depression and anxiety questionnaires and have not had moderate-to-severe symptoms in the past 6 months.
- Your doctor agrees that stopping your antidepressant is a good idea, and you are unsure which way to stop is best.
- You are not pregnant or planning to become pregnant, and you do not have certain other mental health conditions (like bipolar disorder or schizophrenia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test (biomarker) to help pick the antidepressant that might work best for you. It compares two treatments—standard antidepressants and ketamine—in people with major depression who haven't gotten enough relief from one prior treatment.
This study tests a computer-based tool to help choose the next medication for older adults with stubborn depression. It may help match you with a treatment (aripiprazole or bupropion) that is more likely to work for you.
This study looks at whether support from your GP and pharmacist can help you safely stop taking antidepressants you've been on long-term for depression. It aims to find the best way to reduce or stop these medicines without relapse.
This study tests a new way of choosing antidepressants for people with major depression. It's designed for adults aged 19–65 who have moderate to severe depression and are either starting a new antidepressant or have been off psychiatric meds for at least a month.
This study tests whether a “light and ion” treatment can help people with major depression (MDD) who are doing well on antidepressants safely reduce or stop them. You must be in remission and be willing to discontinue for reasons like side effects or personal preference.
This study looks at helping people safely reduce or stop their antidepressant medication with support from their primary care team. It aims to find the best ways to guide patients through this process.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.